The protein p17 signaling pathways in cancer
- Authors
- Heese, Klaus
- Issue Date
- Dec-2013
- Publisher
- SAGE PUBLICATIONS LTD
- Keywords
- Cancer; Oncology; FAM72A; Ugene; p53
- Citation
- TUMOR BIOLOGY, v.34, no.6, pp.4081 - 4087
- Indexed
- SCIE
SCOPUS
- Journal Title
- TUMOR BIOLOGY
- Volume
- 34
- Number
- 6
- Start Page
- 4081
- End Page
- 4087
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161268
- DOI
- 10.1007/s13277-013-0999-1
- ISSN
- 1010-4283
- Abstract
- P17 is a novel neuronal protein expressed under physiological conditions only at very low levels in other tissues. Accumulating data indicate its crucial involvement in tumorigenic effects. Using molecular, cellular, and biocomputational methods, the current study unraveled p17 mode of action. Data indicate that mitochondria-associated p17 interacts with the proteins TMEM115, YPEL3, ERP44, CDK5RAP, and NNAT. Moreover, p17 drives the cell cycle into the G0/G1 phase and enhances survival of proliferating cells. Interference with p17 activities thus might become a novel option to influence also the tumor suppressor protein p53 signaling pathways for the treatment of tumors.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의생명공학전문대학원 > 서울 의생명공학전문대학원 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161268)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.